166 related articles for article (PubMed ID: 33549449)
1. Association of adipocytokines serum levels with left atrial thrombus formation in atrial fibrillation patients on oral anticoagulation (Alert) - A cross-sectional study.
Blessberger H; Mueller P; Makimoto H; Hauffe F; Meissner A; Gemein C; Schmitt J; Hamm C; Deneke T; Schiedat F; Mügge A; Gabriel M; Steinwender C
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):860-868. PubMed ID: 33549449
[TBL] [Abstract][Full Text] [Related]
2. Left atrial thrombus in patients with atrial fibrillation and under oral anticoagulant therapy; 3-D transesophageal echocardiographic study.
Durmaz E; Karpuz MH; Bilgehan K; Ikitimur B; Ozmen E; Ebren C; Polat F; Koca D; Tokdil KO; Kandemirli SG; Atici A; Ongen Z
Int J Cardiovasc Imaging; 2020 Jun; 36(6):1097-1103. PubMed ID: 32140812
[TBL] [Abstract][Full Text] [Related]
3. Low vitamin D levels predict left atrial thrombus in nonvalvular atrial fibrillation.
Çakır OM
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1152-1160. PubMed ID: 32456946
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation.
Wang F; Zhu M; Wang X; Zhang W; Su Y; Lu Y; Pan X; Gao D; Zhang X; Chen W; Xu Y; Sun Y; Xu D
BMC Cardiovasc Disord; 2018 Jul; 18(1):153. PubMed ID: 30064363
[TBL] [Abstract][Full Text] [Related]
5. The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.
Ermakov S; Azarbal F; Stefanick ML; LaMonte MJ; Li W; Tharp KM; Martin LW; Nassir R; Salmoirago-Blotcher E; Albert CM; Manson JE; Assimes TL; Hlatky MA; Larson JC; Perez MV
Heart; 2016 Sep; 102(17):1354-62. PubMed ID: 27146694
[TBL] [Abstract][Full Text] [Related]
6. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
Lin C; Quan J; Bao Y; Hua W; Ke M; Zhang N; Jin Q; Xie Y; Wei Y; Ling T; Pan W; Wu L; Xie Y
J Cardiovasc Electrophysiol; 2020 Mar; 31(3):658-663. PubMed ID: 31975470
[TBL] [Abstract][Full Text] [Related]
7. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
8. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
Bertaglia E; Anselmino M; Zorzi A; Russo V; Toso E; Peruzza F; Rapacciuolo A; Migliore F; Gaita F; Cucchini U; De Divitiis M; Iliceto S; Stabile G
Int J Cardiol; 2017 Dec; 249():179-183. PubMed ID: 29121724
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
Goldman ME; Pearce LA; Hart RG; Zabalgoitia M; Asinger RW; Safford R; Halperin JL
J Am Soc Echocardiogr; 1999 Dec; 12(12):1080-7. PubMed ID: 10588784
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
Hu XF; Zhan R; Xu S; Wang J; Wu J; Liu X; Li Y; Chen L
Clin Cardiol; 2018 Jan; 41(1):34-38. PubMed ID: 29363835
[TBL] [Abstract][Full Text] [Related]
11. Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin.
Vinereanu D; Lopes RD; Mulder H; Gersh BJ; Hanna M; de Barros E Silva PGM; Atar D; Wallentin L; Granger CB; Alexander JH;
Stroke; 2017 Dec; 48(12):3266-3273. PubMed ID: 29089455
[TBL] [Abstract][Full Text] [Related]
12. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
[TBL] [Abstract][Full Text] [Related]
13. Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation.
Choi SW; Kim BB; Choi DH; Park G; Shin BC; Song H; Kim D; Kim DM
Clin Cardiol; 2017 Nov; 40(11):1013-1019. PubMed ID: 28805957
[TBL] [Abstract][Full Text] [Related]
14. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial.
Pol T; Held C; Westerbergh J; Lindbäck J; Alexander JH; Alings M; Erol C; Goto S; Halvorsen S; Huber K; Hanna M; Lopes RD; Ruzyllo W; Granger CB; Hijazi Z
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29419390
[TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation.
Scherr D; Dalal D; Chilukuri K; Dong J; Spragg D; Henrikson CA; Nazarian S; Cheng A; Berger RD; Abraham TP; Calkins H; Marine JE
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):379-84. PubMed ID: 19017348
[TBL] [Abstract][Full Text] [Related]
18. Elevated homocysteine increases the risk of left atrial/left atrial appendage thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score.
Yao Y; Shang MS; Gao LJ; Zhao JH; Yang XH; Liu T; Tang RB; Jiang CX; Long DY; Ning M; Zhu H; Lv Q; Hu R; Du X; Dong JZ
Europace; 2018 Jul; 20(7):1093-1098. PubMed ID: 28637244
[TBL] [Abstract][Full Text] [Related]
19. Left atrial appendage emptying fraction assessed by a feature-tracking echocardiographic method is a determinant of thrombus in patients with nonvalvular atrial fibrillation.
Iwama M; Kawasaki M; Tanaka R; Ono K; Watanabe T; Hirose T; Nagaya M; Noda T; Watanabe S; Minatoguchi S
J Cardiol; 2012 May; 59(3):329-36. PubMed ID: 22342529
[TBL] [Abstract][Full Text] [Related]
20. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.
Cantarini L; Brucato A; Simonini G; Imazio M; Cumetti D; Cimaz R; Bacarelli MR; Muscari I; Vitale A; Lucherini OM; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2013; 31(2):207-12. PubMed ID: 23137677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
